Evidera
Shien Guo has extensive work experience in the field of clinical outcome assessment, modeling and simulation, and research in the pharmaceutical industry. They worked at Evidera since 2013, holding various roles including Vice President of Science, Senior Research Scientist, General Manager/Senior Research Leader, and Senior Director/Senior Research Scientist. Prior to Evidera, they worked at United BioSource Corporation as a Research Scientist and Senior Research Associate.
From 1997 to 2005, Shien Guo attended Saint Louis University. It is not specified whether they obtained a degree or their field of study during this time period.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.